Portfolio company
Jeevatva
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotech company develops microbiome-based microbial products and prebiotics to restore human microbiome homeostasis for patients with metabolic conditions like type 2 diabetes.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
GutCRINE
This company develops microbiome-derived pharmabiotics to treat metabolic and age-related disorders including obesity and type-2 diabetes for patients with chronic diseases.
Myota
This company develops patented prebiotic fibre blends and microbiome testing kits for individual consumers and food and beverage manufacturers.
Una Health
This company develops personalized digital therapy software and biosensor technology for individuals with type 2 diabetes to manage and reverse metabolic dysfunction.
KOBIOLABS
This company develops microbiome-derived therapeutics and live biotherapeutic products for patients with immune, metabolic, neurological and gastrointestinal diseases.
Metabogen
This company develops microbiome-based probiotics and pharmaceuticals for the probiotic and pharmaceutical industries to treat various health conditions.
Amili
This company develops microbiome diagnostic tests, probiotics and gut health therapies for consumers, hospitals and biotechnology firms using an Asian-centric database.
mbiomics
This company develops live bacterial therapeutics and a microbiome profiling platform to treat patients with cancer and inflammatory bowel diseases.
Human Biome
This biotechnology firm develops gut microbiota-based biotherapeutics and fecal microbiota transplantation preparations for medical professionals treating gastrointestinal infections and antibiotic resistance.
